BOSTON & SAN FRANCISCO--(BUSINESS WIRE)--Akili Interactive (“Akili” or “Company"), a leading prescription digital medicine company developing novel treatments for cognitive dysfunction, and the ...

BOSTON--(BUSINESS WIRE)-- Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today announced that its Japanese partner Shionogi & Co. Ltd has submitted Akili’s digital therapeutic SDT-001 ...

Through their shared focus on rigorous clinical validation and high-end user experience, the companies will continue to revolutionize the treatment of children with ...

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company noted that its Founded Entity, Akili Interactive Labs, Inc. (“Akili”), a leading ...

Akili Interactive (“Akili” or “Company”), maker of the first and only prescription video game treatment, today introduced new gaming features and functionalities to its EndeavorRx ? treatment ...

Maker of the first-and-only FDA-cleared prescription video game treatment joins the ranks of Canva, Microsoft, SpaceX, and more BOSTON--(BUSINESS WIRE)-- Akili Interactive Labs, Inc. (“Akili”), a ...

Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, will participate in the Cowen 43 rd Annual Health Care Conference in Boston next month. On March 8, Akili sessions are scheduled for the ...

Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan BOSTON--Akili, Inc. (Nasdaq: AKLI), a leading ...

Akili Interactive (“Akili”), a leading prescription digital therapeutics company and maker of EndeavorRx®, the first and only prescription video game treatment, and Australian Securities Exchange ...